SI-BONE stock has estimated November 9, 2026 earnings date

Published on 10/17/2026 at 19:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SI-BONE has a USD 882.0 million market value. SI-BONE stock was last at EUR 17.50 on October 16, 2026, down 1.16 percent on Nasdaq.

Earnings date and valuation

MarketBeat estimates SI-BONE will report third-quarter results on November 9, 2026.
SI-BONE had a USD 882.0 million market capitalization on October 16, 2026.
SI-BONE stock was last at EUR 17.50 at Lang & Schwarz on October 16, 2026 at 10:59 p.m. CEST, down 1.16 percent on Nasdaq versus the prior close.
SI-BONE had a negative trailing P/E ratio of -57.92 on October 16, 2026.

SIBN, US8257041090, Illustration mit AI erstellt.

SI-BONE stock has an estimated earnings date of November 9, 2026, according to MarketBeat. The report is expected after the market close, with a conference call listed for 4:30 p.m. ET. SI-BONE was last at EUR 17.50 at Lang & Schwarz on October 16, 2026 at 10:59 p.m. CEST, down 1.16 percent on Nasdaq versus the prior close.

Revenue growth remains central

SI-BONE develops minimally invasive products for surgical treatment of sacropelvic disorders. The company says its iFuse platform has treated tens of thousands of patients and is supported by more than 135 peer-reviewed publications, according to its investor-relations page at SI-BONE.

The latest reported quarter ended June 30, 2026. Revenue reached USD 56.01 million, while net income attributable to common shareholders was a loss of USD 4.09 million. Operating margin was minus 9.00 percent for the quarter.

Price position and trading range

SI-BONE closed on Nasdaq at USD 19.68 on October 16, 2026 at 4:00 p.m. ET, down 1.16 percent from USD 19.91. The session ranged from USD 19.19 to USD 19.99, with volume of 1,165,641 shares against an average volume of 554,689 shares.

The 52-week Nasdaq range was USD 11.48 to USD 21.89. The October 16 close stood 10.10 percent below the high and 71.43 percent above the low. The company had a market capitalization of USD 882.0 million and a trailing P/E ratio of -57.92 on that date.

Comparison with peers

SIBN (Nasdaq, USD): minus 1.16 percent, P/E -57.92, market capitalization USD 882.0 million

Globus Medical (Nasdaq, USD): minus 2.70 percent, P/E 19.72, market capitalization USD 10.3 billion

Orthofix Medical (Nasdaq, USD): minus 2.19 percent, P/E -6.11, market capitalization USD 379.2 million

What comes before the report

The November 9, 2026 date is an estimate rather than a company-confirmed calendar entry. MarketBeat lists expected third-quarter revenue of USD 55.27 million and adjusted earnings per share of minus USD 0.13, compared with USD 48.66 million revenue and minus USD 0.11 earnings per share in the year-earlier quarter.

Price and market position

SI-BONE's Nasdaq close of USD 19.68 leaves the stock below its 52-week high, while the euro quotation stood at EUR 17.50 at Lang & Schwarz on October 16, 2026 at 10:59 p.m. CEST. The next scheduled company date is November 9, 2026.

The further course of trading is shown by the continuously updated real-time quote of SIBN stock.